Mvm Partners, Llc Sells 18,109 Shares of Paragon 28, Inc. (NYSE:FNA) Stock

Paragon 28, Inc. (NYSE:FNA) major shareholder Mvm Partners, Llc sold 18,109 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $10.14, for a total value of $183,625.26. Following the transaction, the insider now owns 10,481,851 shares of the company’s stock, valued at approximately $106,285,969.14. The trade was a 0.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Wednesday, November 27th, Mvm Partners, Llc sold 4,256 shares of Paragon 28 stock. The stock was sold at an average price of $10.00, for a total value of $42,560.00.
• On Monday, November 25th, Mvm Partners, Llc sold 10,835 shares of Paragon 28 stock. The stock was sold at an average price of $10.09, for a total value of $109,325.15.
• On Friday, November 22nd, Mvm Partners, Llc sold 72,133 shares of Paragon 28 stock. The shares were sold at an average price of $10.16, for a total value of $732,871.28.
• On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The shares were sold at an average price of $10.28, for a total value of $1,517,132.68.

Paragon 28 Stock Down 1.8 %

Shares of FNA stock traded down $0.19 during midday trading on Friday, reaching $10.03. 406,914 shares of the stock were exchanged, compared to its average volume of 609,491. Paragon 28, Inc. has a 1 year low of $4.65 and a 1 year high of $14.79. The company’s 50 day moving average is $7.38 and its two-hundred day moving average is $7.37. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The firm has a market cap of $839.29 million, a PE ratio of -13.55 and a beta of 1.52.

Paragon 28 (NYSE:FNA) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.01. The company had revenue of $62.30 million for the quarter, compared to the consensus estimate of $60.58 million. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The firm’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.10) EPS. On average, equities research analysts predict that Paragon 28, Inc. will post -0.66 EPS for the current year.

Institutional Trading of Paragon 28

Several hedge funds and other institutional investors have recently made changes to their positions in FNA. First Light Asset Management LLC grew its stake in shares of Paragon 28 by 115.0% in the 2nd quarter. First Light Asset Management LLC now owns 8,174,832 shares of the company’s stock worth $55,916,000 after buying an additional 4,371,864 shares during the last quarter. Millennium Management LLC boosted its stake in Paragon 28 by 5,834.0% during the 2nd quarter. Millennium Management LLC now owns 725,489 shares of the company’s stock valued at $4,962,000 after purchasing an additional 713,263 shares during the last quarter. Peregrine Capital Management LLC purchased a new stake in Paragon 28 during the 2nd quarter valued at $3,351,000. Thrivent Financial for Lutherans boosted its stake in Paragon 28 by 15.4% during the 2nd quarter. Thrivent Financial for Lutherans now owns 1,021,188 shares of the company’s stock valued at $6,986,000 after purchasing an additional 135,911 shares during the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new stake in Paragon 28 during the 2nd quarter valued at $869,000. Hedge funds and other institutional investors own 63.57% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Piper Sandler reaffirmed an “overweight” rating and set a $12.00 price target (down previously from $15.00) on shares of Paragon 28 in a research report on Friday, August 9th. Needham & Company LLC upped their price target on Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Canaccord Genuity Group lowered their price target on Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Finally, Stephens upgraded Paragon 28 to a “strong-buy” rating in a report on Monday. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $15.60.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.